Breaking News

Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here

Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Close

Aeterna Zentaris Inc (AEZS)

	Symbol	Exchange	Currency
	AEZS	Toronto	CAD	Real-time
	AEZS	NASDAQ	USD	Real-time
	ET82	Frankfurt	EUR	Delayed

Add to/Remove from Watchlist Add to Watchlist

0.2054 -0.0001 -0.05%

27/05 - Closed. Currency in USD ( Disclaimer )

After Hours

0.2015

-0.0039

-1.8987%

19:51:29 - Real-time Data

Type: Equity

Market: United States

ISIN: CA0079754028

CUSIP: 007975402

Volume: 365,314
Bid/Ask: 0.0000 / 0.0000
Day's Range: 0.2000 - 0.2107

News
Analysis & Opinion

AEZS Analysis

This page features the latest analysis and reports for the Aeterna Zentaris Inc stock.

Zacks Investment Research

Options Traders Expect Huge Moves In Aeterna Zentaris (AEZS) Stock By Zacks Investment Research - Jun 30, 2019

Investors in Aeterna Zentaris Inc. (TSX:AEZS) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2019 $7.50 Call had some of the...

Zacks Investment Research

What's In The Cards For Aeterna (AEZS) This Earnings Season? By Zacks Investment Research - Mar 03, 2019

Aeterna Zentaris Inc. (TO:AEZS) is likely to report its fourth-quarter 2018 earnings soon.Aeterna’s earnings performance has been encouraging, with the company beating estimates in the last...

Zacks Investment Research

The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent And Aeterna Zentaris By Zacks Investment Research - Feb 26, 2019

For Immediate Release Chicago, IL – February 27, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest...

Zacks Investment Research

4 Drug Stocks To Buy Despite Price Hearing Woes By Zacks Investment Research - Feb 25, 2019

The much-anticipated Congressional hearing over unfair drug pricing is slated to take place on Feb 26. The hearing will establish ground rules for fair drug pricing in America and make way for more...

Zacks Investment Research

The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro And Aeterna By Zacks Investment Research - Feb 13, 2019

For Immediate ReleaseChicago, IL –February 14, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest...

Zacks Investment Research

5 Tiny Biotech Stocks With Superb Growth Potential By Zacks Investment Research - Feb 12, 2019

Market watchers still quibble over whether the equity market entered bear market territory or underwent a correction in year-end 2018. But there is little debate over the fate of pharma stocks during...

Zacks Investment Research

Amgen's Osteoporosis Candidate Evenity Gets Approval In Japan By Zacks Investment Research - Jan 08, 2019

Amgen, Inc. (NASDAQ:AMGN) and its partner UCB announced that its osteoporosis candidate, Evenity (romosozumab) has gained marketing approval in Japan, the first regulatory approval for the pipeline...

Zacks Investment Research

AEterna Zentaris Sees Hammer Chart Pattern: Time To Buy? By Zacks Investment Research - Jan 02, 2019

AEterna Zentaris Inc. (TO:AEZS) has been struggling lately, but the selling pressure may be coming to an end soon. That is because AEZS recently saw a Hammer Chart Pattern which can signal that the...

Zacks Investment Research

Can The Uptrend Continue For Aeterna Zentaris (AEZS)? By Zacks Investment Research - Nov 30, 2018

Investors certainly have to be happy with Aeterna Zentaris Inc. (TO:AEZS) and its short term performance. After all, the stock has jumped by 40.4% in the past 4 weeks, and it is also above its 20...

Zacks Investment Research

Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% In Session By Zacks Investment Research - May 29, 2018

Mirati Therapeutics, Inc. (NASDAQ:MRTX) was a big mover last session, as the company saw its shares rise nearly 14% on the day. The move came on solid volume too with far more shares changing hands...

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

AEZS Comments

Write your thoughts about AEterna Zentaris Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Joel Sebastian Apr 25, 2022 12:43PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I don't know what is really going on with stock

0 0

Ole Rii Mar 24, 2022 11:17AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

2 USD by the end of the year

1 0

John Gomez Mar 24, 2022 11:17AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I hope!

1 0

John Gomez Mar 24, 2022 11:17AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I hope!

1 0

TheJavi GP Nov 26, 2021 5:48AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Sale una nueva variante y no veas la k se lía

0 0

John Napier Oct 01, 2021 9:54AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

why is this 🚀?

0 0

Bruce Hendrickson Oct 01, 2021 9:54AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

There is hype on new COVID treatment announcement and it is/was oversold

0 0

Bruce Hendrickson Sep 30, 2021 9:02PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Seeing a lot of predictions for 3.50 in the next few days

3 0

Brian Solis Sep 30, 2021 9:02PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

why?

0 0

Brian Solis Jul 08, 2021 5:53PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

let's get that oral vaccine out

1 1

Walaa Ahmed Jun 21, 2021 3:50PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Than ?

0 0

Michael Farrell Jun 08, 2021 10:45PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

It's spelled -ess h eye tee-

0 1

Michael Farrell Jun 08, 2021 10:42PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I used to be an enthusiastic bag holder too,...,woke up,dumped the ****

0 0

Glenn AM May 27, 2021 3:14PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

https://www.handelsblatt.com/dpa/wirtschaft-handel-und-finanzen-verband-corona-impfstoffe-zweiter-generation-vielleicht-schon-2021/27222440.html?ticket=ST-5153637-HIXgEEndEVksGk2n6CrC-ap2

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="221506553">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="221506553" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="221506553">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="221506553">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="201153906">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="201153906" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="201153906">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="201153906">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	33,278.1	+640.9	+1.96%
	US 500	4,169.4	+111.6	+2.75%
	Dow Jones	33,212.96	+575.77	+1.76%
	S&P 500	4,158.24	+100.40	+2.47%
	Nasdaq	12,131.13	+390.48	+3.33%
	S&P 500 VIX	25.72	-1.78	-6.47%
	Dollar Index	101.653	-0.205	-0.20%

	Crude Oil WTI	115.07	+0.98	+0.86%
	Brent Oil	115.32	+1.15	+1.01%
	Natural Gas	8.708	-0.187	-2.10%
	Gold	1,851.64	+4.04	+0.22%
	Silver	22.130	+0.165	+0.75%
	Copper	4.3225	+0.0635	+1.49%
	US Soybeans	1,732.50	+6.00	+0.35%

	SPDR S&P 500	415.26	+9.95	+2.45%
	iShares Russell 2000	187.64	+4.92	+2.69%
	Invesco QQQ Trust	309.10	+9.77	+3.26%
	Direxion Daily Junior Gold Miners Bull 2X Shares	53.41	+0.46	+0.87%
	iShares Silver	20.36	+0.05	+0.25%
	ProShares Ultra VIX Short-Term Futures	14.21	-0.88	-5.83%
	ProShares UltraPro QQQ	33.29	+2.97	+9.80%

	Apple	149.64	+5.86	+4.08%
	Alphabet A	2,246.33	+90.48	+4.20%
	Tesla	759.63	+51.90	+7.33%
	Amazon.com	2,302.93	+81.38	+3.66%
	Netflix	195.19	+3.79	+1.98%
	Meta Platforms	195.13	+3.50	+1.83%
	Bank of America	37.02	+0.35	+0.95%

Recent Quotes

	Name	Price	Chg.	Chg. %
	AEZS	0.2054	-0.0001	-0.05%

	Name	Last	Chg. %	Vol.
	AMD	102.26	+3.55%	103.91M
	AAPL	149.64	+4.08%	90.30M
	NVDA	188.11	+5.38%	72.97M
	TSLA	759.63	+7.33%	29.29M
	MSFT	273.24	+2.76%	26.63M
	FB	195.13	+1.83%	22.38M
	AMZN	2,302.93	+3.66%	4.50M

	Name	Last	Chg. %	Vol.
	PDD	48.30	+15.19%	31.70M
	ZS	160.00	+12.57%	6.76M
	ULTA	425.08	+12.47%	2.76M
	ADSK	211.38	+10.31%	2.98M
	DDOG	98.07	+9.42%	6.54M
	MRNA	147.66	+8.73%	7.59M
	MPWR	455.85	+8.11%	544.30K

	Name	Last	Chg. %	Vol.
	WDAY	158.79	-5.57%	13.36M
	BMY	76.14	-1.87%	15.04M
	PM	106.97	-1.02%	6.95M
	CF	95.72	-1.02%	4.03M
	KDP	35.18	-0.99%	11.41M
	C	53.62	-0.87%	19.25M
	ZBH	119.83	-0.68%	922.43K